Decoy Therapeutics Inc. (DCOY)
NASDAQ: DCOY · Real-Time Price · USD
6.24
-0.08 (-1.27%)
Apr 2, 2026, 10:24 AM EDT - Market open
Decoy Therapeutics Market Cap
Decoy Therapeutics has a market cap or net worth of $3.32 million as of April 2, 2026. Its market cap has increased by 122.23% in one year.
Market Cap
3.32M
Enterprise Value
-1.45M
1-Year Change
122.23%
Ranking
Category
Stock Price
$6.24
Market Cap Chart
Since July 22, 2019, Decoy Therapeutics's market cap has decreased from $44.18M to $3.32M, a decrease of -92.49%. That is a compound annual growth rate of -32.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 3.36M | -18.82% |
| Dec 31, 2025 | 4.14M | 56.21% |
| Dec 31, 2024 | 2.65M | 3.58% |
| Dec 29, 2023 | 2.56M | -26.55% |
| Dec 30, 2022 | 3.49M | -84.43% |
| Dec 31, 2021 | 22.39M | 3.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 22, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enveric Biosciences | 4.04M |
| Can-Fite BioPharma | 3.98M |
| Azitra | 3.92M |
| Alzamend Neuro | 3.88M |
| Indaptus Therapeutics | 3.81M |
| GeoVax Labs | 3.70M |
| Genprex | 3.66M |
| Matinas BioPharma Holdings | 3.52M |